Virkningen blev hovedsagelig bedømt på ændringen i symptomerne gennem 26 uger, vurderet på en standardskala (UPDRS, Unified Parkinson’ s Disease Rating Scale).
The main measure of effectiveness was the change in symptoms over 26 weeks, as assessed on a standard scale (Unified Parkinson’ s Disease Rating Scale, UPDRS).